Soleno Therapeutics, Inc. (SLNO) Misses Q1 EPS by 6c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q1 EPS of ($0.95), $0.06 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Medtronic jumps on earnings beat and raised guidance
• Tocvan Provides Corporate Update
• Interactive Brokers (IBKR) call put ratio 1 call 1.2 puts as share price down 6.2%